DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Oncothyreon, Inc. (NASDAQ: ONTY)

1.15 -0.04 (-3.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ONTY $1.15 -3.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.18
Previous Close $1.19
Daily Range $1.13 - $1.19
52-Week Range $1.13 - $4.69
Market Cap $109.2M
P/E Ratio -2.09
Dividend (Yield) $0.00 (0.0%)
Volume 789,029
Average Daily Volume 827,360
Current FY EPS -$0.32

Sector

Healthcare

Industry

Drug Makers

Oncothyreon, Inc. (ONTY) Description

Oncothyreon Inc. is a clinical-stage biopharmaceutical company which is focused on the development of therapeutic products for the treatment of cancer. Website: http://www.oncothyreon.com/

News & Commentary

Oncothyreon Inc (USA) Plunges on Confusing Data

You know management is in trouble when analysts are having trouble understanding the biotech's press release.

Is Oncothyreon (ONTY) Stock a Solid Choice Right Now?

13D Filing From Biotechnology Value Fund On Oncothyreon Reveals 19.8% Stake

Biotech Weekly: Recapping Small- And Mid-Cap Presentations At SABCS

Wednesday Sector Laggards: General Contractors & Builders, Biotechnology Stocks

Benzinga's Top #PreMarket Losers

Tuesday's After-Hours Movers Led By Kinder Morgan, Krispy Kreme And AeroVironment

Oncothyreon Announces Data for ONT-380 in HER2-Positive Breast Cancer Patients With and Without Brai

Oncothyreon Announces Data for ONT-380 in HER2-Positive Breast Cancer Patients With and Without Brain Metastases at the San Antonio Breast Cancer Symposium

Here's Why Oncothyreon's Shares Pushed Higher in November

Oncothyreon's shares rallied last month ahead of the company's forthcoming clinical update for its experimental breast cancer drug ONT-380.

Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology

See More ONTY News...

ONTY's Top Competitors

ONTY $1.15 (-3.36%)
Current stock: ONTY
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
BIIB $263.86 (-3.44%)
Current stock: BIIB